We are monitoring the impact of COVID-19 on MEA Precision Medicine Software Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2021
ID: 11988
Share on
Share on

Middle East and Africa Precision Medicine Software Market Research Report – Segmented By Delivery Mode, Application, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: August, 2021
ID: 11988
Pages: 100

MEA Precision Medicine Software Market Size (2021 to 2026)

The size of the precision medicine software market in the Middle East and Africa is estimated to be growing at a healthy CAGR from 2021 to 2026.

The Middle East and Africa market is expected to experience lucrative growth as IoMT healthcare technologies have increased in recent years. Pharmaceutical and Biotech Companies Attempt to Improve Precision Medicine and Medical Solutions in the Region Diagnostic companies attempt to improve the healthcare industry by adopting various technologies. The adoption of technologies such as next-generation sequencing and gene therapy creates opportunities for the growth of the precision medicine market in the region.

The increase in the incidence of cancer globally implies that anticancer therapies will be sought for its prevention and treatment, which is why it will have most of the therapeutic segment. Furthermore, big data companies are expected to grow for precision medicine technologies in the MEA region due to technological advancements.

In countries of the Middle East and Africa, personal expenditure accounts for almost half of total health expenditure. Therefore, many people have health insurance coverage, especially in rural areas and in the informal sector. African countries have underdeveloped drug supply chains and often face challenges in maintaining an adequate medical workforce. One of the most pressing and unique challenges facing African health systems is the shortage of properly trained health workers due to a lack of training programs, coupled with poor working conditions. These factors may hamper research and development in the market.

Impact of COVID-19 on the MEA precision medicine software market:

With the health sector having a crisis due to pandemics, various solutions are tackling the pandemic. The healthcare industry is dedicated to precision medicine research to understand COVID-19 better and measure the impact caused by the virus to uncover potential therapies. Many MEA authorities have taken initiatives to increase the usage of precision coronavirus drugs. For example, in 2020, the San Antonio Partnership for Precision Therapeutics allocated three COVID-19 collaborative research projects. These projects will support a strong foundation for transformative COVID-19 research taking place across nations. The Cleveland Clinic has also introduced a genomic medicine experiment to find genetic factors that are susceptible to the virus and use them to develop preventive and treatment strategies against the virus.

The research report on the MEA precision medicine software market has been segmented and sub-segmented into the following categories.

By Delivery Mode:

  • Web & Cloud-Based
  • On-Premise

By Application:

  • Oncology
  • Pharmacogenomics
  • Rare Diseases
  • Other Applications

By End User:

  • Healthcare Providers
  • Research Centers and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

In African countries, the increasing prevalence of diseases such as HIV, malaria, tuberculosis, etc., justifies the use of precision drugs, which is expected to drive the market. Another factor that can be attributed to their growth is the ability of the people of the Middle East to pay for precision medicine. The growing demand for personalized medicine coupled with the adoption of the technology in the region is driving the growth of the precision medicine market.

In Turkey, cancer is one of the leading causes of death, followed by cardiovascular disease. In addition, the incidence rate of cancer is increasing dramatically, increasing the need for an advanced health system. For example, GLAB formed a foundation for preventive medicine related to inherited breast and colon cancer, further integrating precision medicine into the healthcare system. In addition, growing collaborations between companies are expected to boost the implementation of precision medicine. Hence, these developments are intended to create multiple growth opportunities for the precision medicine market in Turkey.

Likewise, there is a high growth potential for precision medicine in South Africa due to the increasing prevalence of infections and non-communicable diseases. In addition, several initiatives are underway to improve the availability of research data, complementing the growth of the genomics industry. For example, the African Genome Center is under construction, increasing the country's capacity to sequence the human genome. These developments would help accelerate the diagnosis and treatment of various diseases, including cancer, thereby supporting the precision medicine market in South Africa.

KEY MARKET PLAYERS:

A few of the notable companies operating in the MEA precision medicine software market profiled in this report are SOPHiA GENETICS SA, Syapse, Inc., Foundation Medicine, Inc., 2bPrecise LLC, Fabric Genomics, Human Longevity, Inc., Translational Software, Inc., Gene42, Inc., IBM Watson Group, LifeOmic Health, LLC, Sunquest Information Systems Inc., Koninklijke Philips N.V., and Flatiron Health, Inc.

  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions
    4. Base Currency, Base Year and Forecast Periods
  2. Research Methodology
    1. Analysis Design
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Data Modelling
      4. Expert Validation
    3. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking
      1. Market share analysis
      2. Products/Service
      3. Regional Presence
    2. Mergers & Acquisition Landscape
    3. Joint Ventures & Collaborations
  6. Market Segmentation
    1. Precision Medicine Software Market, By Delivery
      1. Web & Cloud Based
      2. On-Premise
      3. Market Size Estimations & Forecasts (2021-2026)
      4. Y-o-Y Growth Rate Analysis
      5. Market Attractiveness Index
    2. Precision Medicine Software Market, By Application
      1. Oncology
      2. Pharmacogenomics
      3. Rare Diseases
      4. Other Applications
      5. Market Size Estimations & Forecasts (2021-2026)
      6. Y-o-Y Growth Rate Analysis
      7. Market Attractiveness Index
    3. Precision Medicine Software Market, By End User
      1. Healthcare Providers
      2. Research Centers and Academic Institutes
      3. Pharmaceutical and Biotechnology Companies
      4. Other End Users
      5. Market Size Estimations & Forecasts (2021-2026)
      6. Y-o-Y Growth Rate Analysis
      7. Market Attractiveness Index
  7. Geographical Landscape
    1. Precision Medicine Software Market, by Region
    2. The Middle East and Africa
      1. By Country
        1. Middle East
        2. Africa
  8. Key Player Analysis
    1. SOPHiA GENETICS SA
      1. Business Description
      2. Products/Service
      3. Financials                             
      4. SWOT Analysis
      5. Recent Developments
      6. Analyst Overview
    2. Syapse, Inc.
    3. Foundation Medicine, Inc.
    4. 2bPrecise LLC
    5. Fabric Genomics
    6. Human Longevity, Inc.
    7. Translational Software, Inc.
    8. Gene42, Inc.
    9. IBM Watson Group
    10. LifeOmic Health, LLC
    11. Sunquest Information Systems Inc.
    12. Koninklijke Philips N.V.
    13. Flatiron Health, Inc.
  9. Market Outlook & Investment Opportunities
  10. Appendix                                               
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of delivery mode, application and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Middle East and Africa Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  2. Middle East and Africa Web & Cloud-Based Market, By Region, From 2021 to 2026 (USD Billion)
  3. Middle East and Africa On-Premise Market, By Region, From 2021 to 2026 (USD Billion)
  4. Middle East and Africa Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  5. Middle East and Africa Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  6. Middle East and Africa Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Billion)
  7. Middle East and Africa Rare Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  8. Middle East and Africa Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  9. Middle East and Africa Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  10. Middle East and Africa Healthcare Providers Market, By Region, From 2021 to 2026 (USD Billion)
  11. Middle East and Africa Research Centers and Academic Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  12. Middle East and Africa Pharmaceutical and Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
  13. Middle East and Africa Other End Users Market, By Region, From 2021 to 2026 (USD Billion)
  14. Middle East Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  15. Middle East Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  16. Middle East Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  17. Africa Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  18. Africa Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  19. Africa Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample